Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human β-globin locus

  1. Dirk Schübeler1,4,
  2. Claire Francastel1,4,
  3. Daniel M. Cimbora1,
  4. Andreas Reik1,
  5. David I.K. Martin2, and
  6. Mark Groudine1,3,5
  1. 1Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 USA; 2The Victor Chang Cardiac Research Institute, Darlinghurst, Sydney, NSW 2010, Australia; 3Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington 98104 USA

Abstract

We have investigated the mechanism, structural correlates, andcis-acting elements involved in chromatin opening and gene activation, using the human β-globin locus as a model. Full transcriptional activity of the human β-globin locus requires the locus control region (LCR), composed of a series of nuclease hypersensitive sites located upstream of this globin gene cluster. Our previous analysis of naturally occurring and targeted LCR deletions revealed that chromatin opening and transcriptional activity in the endogenous β-globin locus are dissociable and dependent on distinctcis-acting elements. We now report that general histone H3/H4 acetylation and relocation of the locus away from centromeric heterochromatin in the interphase nucleus are correlated and do not require the LCR. In contrast, LCR-dependent promoter activation is associated with localized histone H3 hyperacetylation at the LCR and the transcribed β-globin-promoter and gene. On the basis of these results, we suggest a multistep model for gene activation; localization away from centromeric heterochromatin is required to achieve general hyperacetylation and an open chromatin structure of the locus, whereas a mechanism involving LCR/promoter histone H3 hyperacetylation is required for high-level transcription of the β-globin genes.

Keywords

Footnotes

  • 4 These authors contributed equally to this work.

  • 5 Corresponding author.

  • E-MAIL markg{at}fhcrc.org; FAX (206) 667-5894.

    • Received February 2, 2000.
    • Accepted March 13, 2000.
| Table of Contents

Life Science Alliance